Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03457402 · ClinicalTrials.gov registry record · NA
Shaping Tolerance for Delayed Rewards
A NA study of Impulsivity, sponsored by University of California, Davis.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03457402: Recruiting NA study of Impulsivity, sponsored by University of California, Davis.
NCT03457402 is a NA study of Impulsivity that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 50 participants, above the 33-participant average among 4 other Impulsivity trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03457402, a NA study of Impulsivity, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Deficits in self-control are of major public health relevance as they contribute to several negative outcomes for both individuals and society. For children, developing self-control is a critically important step toward success in academic settings and social relationships, yet there are few non-pharmacological approaches that have been successful in increasing self-control. We found in our earlier studies that self-control can be increased in preschool-aged children with high impulsivity by using games in which they practice gradually increasing wait-time for larger, more delayed rewards. We are performing this current study to test if this training to increase self-control can be increased using mobile app technology, with computerized game time being used as a reward.
Primary Outcome
The indifference point on the tablet-task assessment is defined as the delay interval at which the child chooses 50% longer, larger rewards and 50% shorter, smaller rewards. Investigators hypothesize that the shaping group will have greater increases in their indifference points than the waitlist control group.
Conditions Studied
Interventions
- BEHAVIORAL Shaping Delay Tolerance
Study Locations (1)
California
- UC Davis MIND Institute - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-09-12 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT03457402 shows while recruiting
NCT03457402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, above the 33-participant average among 4 other Impulsivity trials with a reported enrollment target (52% higher).
The record links to 1 condition, with Impulsivity appearing as the primary indexed condition, and to 1 intervention - of which Shaping Delay Tolerance is the first listed.
NCT03457402 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03457402 about?
NCT03457402 is a clinical study titled "Shaping Tolerance for Delayed Rewards". Deficits in self-control are of major public health relevance as they contribute to several negative outcomes for both individuals and society. For children, developing self-control is a critically important step toward success in academic settings and social relationships, yet there are few non-pha...
What is the current status of trial NCT03457402?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2017-09-12. Estimated completion is 2026-05.
What conditions does trial NCT03457402 study?
This clinical trial studies the following conditions: Impulsivity.
What interventions are being tested in trial NCT03457402?
The interventions under investigation include: Shaping Delay Tolerance (BEHAVIORAL).
Who is sponsoring clinical trial NCT03457402?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03457402 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Impulsivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Combined tDCS and Cognitive Training to Reduce Impulsivity in Patients With Traumatic Brain Injury
ACTIVE NOT RECRUITING · NA
-
The Gut-brain Axis in Food Reward and Alcohol Consumption
COMPLETED · NA
-
Effects of Neuromodulation and Cognitive Training for Suicide in Veterans (ENACTS)
COMPLETED · NA
-
Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI